Previous 10 | Next 10 |
home / stock / tevjf / tevjf news
A stricter interpretation of anti-kickback rules Yet another kickback scheme allegation hit Teva ( TEVA ) yesterday, sending its stock down over 10%. - New about this umpteenth lawsuit, however, was that it related to Copaxone, i.e. Teva's own drug, so this time Teva could not point to ...
Quick Take Harmony Biosciences Holdings ( HRMY ) intends to raise $100 million from the sale of its common stock in an IPO, according to an amended registration statement. The company is advancing development and commercialization of narcolepsy and related treatments. HRMY has shown a st...
Teva Pharmaceutical Industries Limited (TEVA) Q2 2020 Earnings Conference Call August 05, 2020 08:00 AM ET Company Participants Kevin Mannix - Senior Vice President, Investor Relations Kare Schultz - Chief Executive Officer Eli Kalif - Chief Financial Officer Brendan O'Grady - ...
The following slide deck was published by Teva Pharmaceutical Industries Limited in conjunction with their 2020 Q2 earnings Read more ...
Quick Take Harmony Biosciences Holdings ( HRMY ) has filed to raise $100 million in an IPO of its common stock, according to an S-1 registration statement . The firm is a biopharma commercializing its WAKIX molecule for the treatment of excessive sleepiness in adult narcolepsy. HRMY has...
Musings May’s risk-on environment baffled many (and again caused soul searching amongst dividend and value investors. How long can factors (which has proven to create alpha over long stretches of time) continue to lag the market? As John Maynard Keynes aptly phrased it, ȁ...
Quick Take Avidity Biosciences ( RNA ) has filed to raise $100 million in an IPO of its common stock, according to an S-1 registration statement. The firm is developing treatments for diseases including various dystrophies and Pompe disease. RNA is a very early stage firm but has a sig...
This article is part of a series that provides an ongoing analysis of the changes made to Berkshire Hathaway’s 13F stock portfolio on a quarterly basis. It is based on Warren Buffett’s regulatory 13F Form filed on 05/15/2020. Please visit our Tracking 10 Years Of Berkshire Hat...
Teva Pharmaceutical Industries Limited (TEVA) Q1 2020 Earnings Conference Call May 07, 2020, 08:00 AM ET Company Participants Kevin Mannix - Senior Vice President, Head of Investor Relations Kare Schultz - President & Chief Executive Officer Eli Kalif - Executive Vice Preside...
The following slide deck was published by Teva Pharmaceutical Industries Limited in conjunction with their 2020 Q1 earnings Read more ...
News, Short Squeeze, Breakout and More Instantly...
Teva Pharmaceutical Industries Ltd Company Name:
TEVJF Stock Symbol:
OTCMKTS Market:
Teva Pharmaceutical Industries Ltd Website: